Loading
Spread causes around nine in ten cancer deaths but receives a small slice of research funding. A funding floor would change what gets studied.
Portfolio analyses have repeatedly put metastasis research at roughly 5-10% of cancer research spend. A committed floor, with a transparent classification method, an annual public report and a dedicated review panel that understands metastasis models, is a pure policy lever with no scientific risk, only allocation risk.
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
Shares GLOBOCAN / Global Cancer Observatory, Funding follows fashion, not burden.
Shares GLOBOCAN / Global Cancer Observatory, Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
Shares Funding follows fashion, not burden, National Cancer Institute (NIH).
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).